Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01995188
Title A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Patients With Ovarian Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital. Boston Massachusetts 02114 United States Details
Dana Farber Cancer Inst. Boston Massachusetts 02115 United States Details
The University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
The Sarah Cannon Research Inst Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field